Cisatracurium Besylate 70436-0112-82

Package NDC

70436-0112-82

Manufacturer: Slate Run Pharmaceuticals, Llc
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: September 2, 2021
Listing Expires: December 31, 2026
Application: ANDA216539

Need to source Cisatracurium Besylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cisatracurium Besylate	2 mg/mL

Drug Class

Neuromuscular Nondepolarizing Blockade [PE]Nondepolarizing Neuromuscular Blocker [EPC]

Selected Package

70436-0112-82Selected

10 VIAL, SINGLE-DOSE in 1 CARTON (70436-112-82) / 5 mL in 1 VIAL, SINGLE-DOSE